Lactobacillus casei
Also known as: L. casei, Lacticaseibacillus casei, L. paracasei Shirota, Shirota strain, DN-114 001, Lc-11
Lactobacillus casei is a lactic acid bacterium closely related to L. paracasei and L. rhamnosus, best known from fermented milk drinks built on the Shirota strain, which has been studied in randomized trials for irritable bowel symptoms and for constipation-related outcomes. It is used in digestive and immune blends and as a companion to Bifidobacterium strains. Supplement suppliers offer freeze-dried L. casei at 1–10 billion CFU per serving; nomenclature is in flux, so strain codes and the updated genus name may both appear on certificates of analysis.
Research summary
Produces lactic acid; studied for effects on gut transit and on mucosal immune signaling.
Dosage
Daily amounts, of compound. CFU shown in billions.
| Lowest studied | Typical range | Highest studied | Upper limit |
|---|---|---|---|
| 1 B CFU | 1–10 B CFU | — | — |
Amounts are in billions of CFU (enter 5 for 5 billion). Raw-material weight assumes a 100 billion CFU/g concentrate (10 mg per billion CFU); manufacturers add a 20–50% CFU overage at fill so the label claim holds through shelf life, and the label should state whether CFU are guaranteed at manufacture or at expiry. Most Shirota data come from fermented milk rather than freeze-dried capsules.
Standardization: Strain-designated freeze-dried culture; CFU per gram on CoA
Source material: freeze-dried culture
As supplied: Assumes 100 billion CFU/g concentrate (10 mg per billion CFU); adjust to supplier CoA.
Forms of Lactobacillus
| Form | Typical dose | Element % | Formats | Price |
|---|---|---|---|---|
| Lactobacillus casei | 1–10 B CFU | — | Capsule, Powder | mid |
| Lactobacillus acidophilus | 1–10 B CFU | — | Capsule, Powder | mid |
| Lactobacillus reuteri (DSM 17938) | 0.1–1 B CFU | — | Capsule, Powder | high |
| Lactobacillus plantarum | 1–10 B CFU | — | Capsule, Powder | mid |
| Lactobacillus gasseri | 1–10 B CFU | — | Capsule, Powder | mid |
Format suitability
- Capsule
- Powder
- Tablet
- Softgel
- Gummy
- Liquid
Heat- and moisture-sensitive vegetative cells; capsule or dry powder only.
Formulation notes
Separate from antibiotic dosing by at least two hours. Often grown on dairy-based media; confirm allergen status with the supplier.
Sources
- NIH ODS — Probiotics Fact Sheet for Health ProfessionalsNIH ODS
- Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome. (Thijssen 2016)PubMed
- Effects of Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial. (Zhang 2021)PubMed
Related ingredients
Probiotic Blend (Multi-Strain)
ProbioticA generic placeholder for a multi-strain probiotic blend, typically combining several Lactobacillus and Bifidobacterium species and sometimes Streptococcus thermophilus or a Bacillus spore.
Typical: 10–50 B CFU
Lactobacillus rhamnosus GG (LGG)
ProbioticLGG (Lactobacillus rhamnosus GG, ATCC 53103) is the single most studied probiotic strain, isolated in 1985 and since reclassified as Lacticaseibacillus rhamnosus.
Typical: 1–10 B CFU
Bifidobacterium lactis
ProbioticBifidobacterium animalis subsp.
Typical: 1–10 B CFU
Saccharomyces boulardii
ProbioticSaccharomyces boulardii is a probiotic yeast rather than a bacterium, originally isolated from lychee and mangosteen skins.
Typical: 5–10 B CFU
L-Glutamine
Amino acidThe most abundant free amino acid in blood and muscle and a primary fuel for intestinal and immune cells.
Typical: 5–10 g